What Omicron could mean for the pandemic

Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

The day after Thanksgiving 2021 the news of a new variant with several mutations was announced and quickly named Omicron, as well as a variant of concern. It has since become the predominant variant causing COVID-19 cases.

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

Recent Videos
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jillian Cotter, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Tina Tan, MD
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Measles outbreaks: 223 cases reported in Texas | Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Related Content
Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels | Image Credit: © Monir - © Monir - stock.adobe.com.

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels

Joshua Fitch, Senior Editor
June 5th 2025
Article

Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

County-level data set reveals widespread decline in MMW vaccination rates in the United States | Image Credit: © Leigh Prather - © Leigh Prather - stock.adobe.com.

County-level data set reveals widespread decline in MMR vaccination rates in the United States

Joshua Fitch, Senior Editor
June 4th 2025
Article

The data found complements state- and national-level CDC data, confirming widespread declines in MMR vaccination rates.

Vaccines in the medical home

Vaccines in the medical home

Miranda Hester
December 17th 2021
Podcast

Contemporary Pediatrics sat down with Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, to discuss the importance of maintaining a strong medical home and the value of vaccination remaining in it, particularly the COVID-19 vaccine.

Expert reactions to new COVID-19 vaccine policies

Expert reactions to new COVID-19 vaccine policies

Joshua Fitch, Senior Editor
May 30th 2025
Article

Federal health agencies have adjusted COVID vaccine guidance, potentially changing eligibility and access for pediatric patients. Experts respond in this article.

Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months

Joshua Fitch, Senior Editor
May 29th 2025
Article

New phase 3b durability data revealed nirsevimab reduced RSV hospitalizations in infants by 82.7% through 180 days vs no intervention.

© 2025 MJH Life Sciences

All rights reserved.